Is there a role for TNFα antagonists in the treatment of Systemic Sclerosis (SSc)?
Posted 02 February 2012 - 06:44 AM
Most of the experts do not recommend the routine use of TNF-α antagonists in systemic sclerosis. Arthritis might be a potential indication, although controlled clinical trials are needed before general recommendations can be given. Clin Exp Rheumatol. 2011 Mar-Apr;29(2 Suppl 65):S40-5. (Also see: Biologics)
This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.
ISN Assistant Webmaster
ISN Sclero Forums Manager
ISN News Manager
ISN Hotline Support Specialist
ISN Chat Host
International Scleroderma Network (ISN)